semaglutide companies Novo Nordisk tackles harm from Ozempic fakes with global authorities Semaglutide: price and HTA comparison

Foods That Increase GLP-1 Levels Several categories of natural nutrients have been shown to stimulate GLP-1 secretion: Protein Consuming high-protein foods like meat, fish, eggs, and plant-based proteins triggers the release of GLP-1, improving satiety and blood sugar control

In a study of 40 men with type 2 diabetes, 1 mg of semaglutide per week for 6 months significantly reduced circulating IL-6 levels

Food and Drug Administration approved Ozempic in 2017 and Wegovy, which has higher doses of semaglutide, in 2021

Phase 2: Market Creation at Scale Novo Nordisk didnt just innovateit scaled demand aggressively: Positioned GLP-1 as a dual-solution drug (diabetes + weight loss) Expanded into non-diabetic populations seeking weight management Invested heavily in manufacturing and global supply chains Built direct-to-consumer channels to improve access By 2025: GLP-1 drugs became the primary growth driver for the company Novo Nordisk held a dominant share in the GLP-1 market Demand surged globally, driven by rising obesity and diabetes rates The broader GLP-1 market is now expected to grow at ~14% CAGR, driven by lifestyle diseases and expanding use cases